Avita Medical
RCEL
80 hedge funds and large institutions have $119M invested in Avita Medical in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 10 closing their positions.
1.81% more ownership
Funds ownership: 30.05% → 31.86% (+1.8%)
5% more call options, than puts
Call options by funds: $563K | Put options by funds: $535K
0% more funds holding
Funds holding: 80 → 80 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
8% less capital invested
Capital invested by funds: $129M → $119M (-$10.7M)
31% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.39M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$2.59M |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
+$2.12M |
| 4 |
Morgan Stanley
New York
|
+$2.07M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.29M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$2.44M |
| 3 |
Two Sigma Investments
New York
|
-$1.06M |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$690K |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
-$632K |
RCEL Hedge Fund Activity: Q3 2023 in Review
80 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q3 2023, worth a combined $119M — down 8.3% from $129M a quarter earlier.
Fund positioning in RCEL was balanced in Q3 2023: 10 funds opened new positions, 10 closed out, 22 added to existing stakes and 32 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $8.39M. The largest seller was Millennium Management, cutting an estimated $4.29M.
- 80 institutional investors held Avita Medical (RCEL) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $119M of Avita Medical stock for Q3 2023, down 8.3% quarter-over-quarter.
- 10 funds opened new Avita Medical positions in Q3 2023 and 10 closed out, a net change of 0 holders.
- The largest Avita Medical buyer in Q3 2023 was Driehaus Capital Management, an estimated $8.39M added.
- The largest Avita Medical seller in Q3 2023 was Millennium Management, an estimated $4.29M sold.
Based on aggregated 13F filings for Q3 2023.